Literature DB >> 29249430

Prevalence of Takayasu arteritis in young women with acute ischemic heart disease.

Giulio Cavalli1, Alessandro Tomelleri1, Davide Di Napoli2, Elena Baldissera3, Lorenzo Dagna4.   

Abstract

OBJECTIVES: Takayasu arteritis (TA), a systemic vasculitis typically occurring in female patients aged ≤40, can affect coronary arteries and cause ischemic heart disease (IHD). In this study, we investigated the prevalence of TA in young women presenting with IHD in the Emergency Department.
METHODS: We evaluated hospital records of 158,860 consecutive female patients aged <40, who accessed the Emergency Department of our institution over 8 consecutive years (2007-2015). The prevalence of different etiologies of IHD was determined. Diagnosis of TA was established based on the 1990 ACR criteria.
RESULTS: Overall, 1950 women aged <40 presented to the Emergency Department with chest pain, dyspnea, palpitations, angina, heart failure, or cardiac arrest; 40 had acute IHD. The etiology was 'classic' atherosclerosis in 24 cases (60%), TA in 4 cases (10%), vasospasm and sympathomimetic drug abuse in 3 cases each (7.5%), coronary artery dissection and microvascular angina in 2 cases each (5%), Takotsubo and radiation-induced cardiomyopathy in 1 case each (2.5%). DISCUSSION: Although a diagnosis of TA is likely to be overlooked, TA is not infrequent in younger females presenting with acute IHD, a finding relevant to the diagnosis and management of these patients.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ischemic heart disease; Myocardial infarction; Takayasu arteritis; Vasculitis

Mesh:

Substances:

Year:  2018        PMID: 29249430     DOI: 10.1016/j.ijcard.2017.10.067

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Cardiogenic shock as the first manifestation of large vessel vasculitis in a young patient: case report.

Authors:  Nicolas Isaza; Adriana Maria Posada; Mauricio Eduard Diaz; Daniel Isaza-Restrepo
Journal:  Eur Heart J Case Rep       Date:  2018-08-03

Review 2.  Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.